Pharmaceutical and nutraceutical companies sourcing raw psyllium husk (Plantago ovata) face strict quality and regulatory protocols. Depending on the destination market, the active raw material must align exactly with regional pharmacopoeias: the United States Pharmacopeia (USP), the European Pharmacopoeia (EP), or the Indian Pharmacopoeia (IP).
Mismatches in swelling volume or ash content can lead to batch rejections during formulation or import compliance failures at customs. Understanding how these testing monographs vary, particularly regarding laboratory testing methods and chemical purity margins, is a vital prerequisite for procurement managers and quality assurance teams.